𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug interactions and protease inhibitors used in the treatment of hepatitis C: How to manage?

✍ Scribed by S. Talavera Pons; G. Lamblin; A. Boyer; V. Sautou; A. Abergel

Book ID
121822398
Publisher
Springer
Year
2014
Tongue
English
Weight
313 KB
Volume
70
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Management of drug-to-drug interactions
Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients
✍ Martin Vogel; Esther Voigt; Hans-Christoph Michaelis; Thomas Sudhop; Martin Wolf πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 1 views

Highly active antiretroviral therapy (HAART) has improved the life expectancy of HIV-infected patients, allowing orthotopic liver transplantation as a reasonable treatment option for selected patients with terminal liver disease. Both non-nucleoside reverse transcriptase inhibitors and protease inhi

ChemInform Abstract: Challenges in Moder
ChemInform Abstract: Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
✍ F. George Njoroge; Kevin X. Chen; Neng-Yang Shih; John J. Piwinski πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons βš– 24 KB πŸ‘ 3 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v